NovaBay Pharmaceuticals’ Non-antibiotic Anti-infective Successful in Phase 2 Trial
NovaBay Pharmaceuticals, Inc. announces its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. […]